The American Heart Association issued a recommendation for all children currently taking or diagnosed to begin taking prescription ADD / ADHD medication to receive a thorough cardiovascular screening . This warning follows last year’s FDA ordinance to ADD/ADHD drug manufacturers to include warning labels on drugs regarding the increased risk for cardiac complications among those with underlying heart conditions , as prescription ADD/ADHD stimulants raise both heart rate and blood pressure. What makes this discovery more disturbing in regards to the risk of heart troubles surrounding these medications is that heart disease often goes undetected in children . The AHA reports suggest that 33 to 42 percent of pediatric heart patients also have ADD / ADHD . From 1999 to 2004, the FDA reported 19 children on prescription ADD/ADHD medicine who died suddenly, and 26 showed signs of heart complications , including stroke , heart attack, pain , and/or heart palpitations . In addition, Health Canada (the Canadian version of the FDA) banned Adderall, a commonly prescribed drug for ADD / ADHD , after a review of FDA records of self-reported deaths of 12 American children.

See the rest here:
Heart Screening Alert for ADD/ADHD Children